The purpose of this study is to describe design considerations for the use of flow cytometry (FC) com-pared to51chromium (51Cr)-release assays utilizing cryopreserved peripheral blood mononuclear cells (PBMCs) to detect natural killer (NK) cell cytotoxicity. Subjects were 10 healthy women aged 18 to 39 years. Intra-assay variability between methods differed only at the lowest effector-target ratios evaluated. Interassay variability was wide but did not differ between methods. The relationship of lytic unit-10 between methods was strongly positive. Cytotoxicity detected by51Cr release was higher than that detected by FC for all 10 subjects. Cost was comparable. How-ever, had more assays been performed, technician time would have been greater with flow cytometry. More whole blood was needed to perform the flow cytometry cytotoxicity assay than51Cr-release cytotoxicity assay. The authors found no compelling reason to adopt NK cell cytotoxicity by flow cytometry over51Cr release.
References
1.
Chang L, Gusewitch GA, Chritton DBW, Folz JC, Lebeck LK, Nehlsen-Cannarella SL. 1993. Rapid flow cytometric assay for the assessment of natural killer cell activity. J Immunol Methods166:45-54.
2.
Derby EG, Reddy V, Nelson EL, Kopp WC, Baseler MW, Dawson JR, Malyguine AM. 2001. Correlation of human CD56+ cell cytotoxicity and IFN-gamma production. Cytokine13(2):85-90.
3.
Ellis TM. 1993. Flow cytometric assays of cell-mediated cytotoxicity. In: Bauer KD, Duque RE, Shankey TV, editors. Clinical flow cytometry. Principles and application. Baltimore (MD): Williams & Wilkins. p 497-503.
4.
Fawzy FI, Kemeny ME, Fawzy NW, Elashoff R, Morton D, Cousins N, Fahey JL. 1990. A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry47:729-735.
5.
Friberg D, Bryant J, Shannon W, Whiteside TL. 1994. In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation. Clin Diagn Lab Immunol1(3):261-268.
6.
Friberg DD, Bryant JL, Whiteside TL. 1996. Measurements of natural killer (NK) activity and NK-cell quantification. Methods9(2):316-326.
7.
Fukunaga M, Yielding KL. 1978. Propidium: induction of petites and recovery from ethidium mutagenesis in Saccharomyces cerevisiae. Biochem Biophys Res Commun84(2):501-507.
8.
Fukunaga M, Yielding LW, Firth WJ III, Yielding KL. 1981. Comparison of petite induction in yeast by acridines, ethidium and their photoaffinity probes. Mutat Res82(1):87-93.
9.
Gatti G, Del Ponte D, Cavello R, Sartori ML, Salvadori A, Carignola R, Carandente F, Angeli A. 1987. Circadian changes in human natural killer-cell activity. Prog Clin Biol Res227A:399-409.
10.
Godoy-Ramirez K, Franck K, Gaines H. 2000. A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry. J Immunol Methods239(1-2):35-44.
11.
Hatam L, Schuval S, Bonagura VR. 1994. Flow cytometric analysis of natural killer cell function as a clinical assay. Cytometry16:59-68.
12.
Irwin M, Lacher U, Caldwell C. 1992. Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects. Psychol Med22(4):1045-1050.
13.
Kane KL, Ashton FA, Schmitz JL, Folds JD. 1996. Determination of natural killer cell function by flow cytometry. Clin Diagn Lab Immunol3(3):295-300.
14.
Kawai H, Komiyama A, Katoh M, Yabuhara A, Miyagawa Y, Akabane T. 1988. Induction of lymphokine-activated killer and natural killer cell activities from cryopreserved lymphocytes. Transfusion28:531-535.
15.
Kiecolt-Glaser JK, Glaser R, Strain EC, Stout JC, Tarr KL, Holliday JE, Speicher CE. 1986. Modulation of cellular immunity in medical students. J Behav Med9:5-21.
16.
Molecular Probes Inc. 1999. Material data safety sheet: 3, 3'-dioctadecyloxacarbocyanine perchlorate. Eugene (OR): Molecular Probes Inc.
17.
Molecular Probes Inc. 2001. LIVE/DEAD® cell-mediated cytotoxicty kit (L-7010). Eugene (OR): Molecular Probes Inc.
18.
Motzer SA, Jarrett M, Heitkemper MM, Tsuji J. 2002. Natural killer cell function and psychological distress in women with and without irritable bowel syndrome. Biol Res Nurs4(1):31-42.
19.
Piriou L, Chilmonczyk S, Genetet N, Albina E. 2000. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species. Cytometry41(4):289-297.
20.
Pross HF, Baines MG. 1982. Studies of human natural killer cells. I. In vivo parameters affecting normal cytotoxic function. Int J Cancer29:383-390.
21.
Pross HF, Baines MG, Rubin P, Shragge P, Patterson MS. 1981. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol1(1):51-63.
22.
Pross HF, Maroun JA. 1984. The standardization of NK cell assays for use in studies of biological response modifiers. J Immunol Methods68:235-249.
23.
RadosevicK, Garritsen HS, Van Graft M, De Grooth BG, Greve J. 1990. A simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells. J Immunol Methods135(1-2):81-89.
24.
See DM, Khemka P, Sahl L, Bui T, Tilles JG. 1997. The role of natural killer cells in viral infections. Scand J Immunol46(3):217-224.
25.
Sieber WJ, Rodin J, Larson L, Ortega S, Cummings N, Levy S, Whiteside T, Herberman R. 1992. Modulation of human natural killer cell activity by exposure to uncontrollable stress. Brain Behav Immun6:141-156.
26.
Sigma Chemical Company. 1994. Material safety data sheet: 3, 3'-dioctadecyloxacarbocyanine perchlorate. St. Louis, MO: Sigma Chemical Company.
27.
Whiteside TL, Bryant J, Day R, Herberman RB. 1990. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J Clin Lab Anal4(2):102-114.
28.
Whiteside TL, Herberman RB. 1989. The role of natural killer cells in human disease. Clin Immunol Immunopathol53:1-23.
29.
Whiteside TL, Herberman RB. 1994. Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol1(2):125-133.
30.
Whiteside TL, Wilson J, Bryant J, Zeevi A, Abu el-Magd K, Jain A, Alessiani M, Fung J, Herberman RB, Starzl TE. 1991. Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. Transplant Proc23(6):3047-3051.
31.
Winkelstein A, Donnenberg AD. 1997. Clinical application of flow cytometry. In: Leffell MS, Donnenberg AD, Rose NR, editors. Handbook of human immunology. Boca Raton (FL): CRC Press. p 381-476.
